PFIZER INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 191
- Registration Number
- NCT00930059
- Locations
- 🇺🇸
Lake Charles Clinical Trials, LLC, Lake Charles, Louisiana, United States
🇺🇸Neurocare, Inc., Newton, Massachusetts, United States
🇨🇦Medical Arts Health Research Group, Kelowna, British Columbia, Canada
A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2019-01-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 80
- Registration Number
- NCT00929981
- Locations
- 🇮🇳
Pfizer Investigational Site, Ludhiana, Punjab, India
A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 329
- Registration Number
- NCT00930722
- Locations
- 🇮🇳
Pfizer Investigational Site, Kolkata, West Bengal, India
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: DMARDs or Biologics
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2011-08-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 156
- Registration Number
- NCT00929357
A Global Active Surveillance for Community Acquired Pneumonia
Not Applicable
Completed
- Conditions
- Community Acquired Pneumonia
- Interventions
- Procedure: Blood drawProcedure: Chest X-rayProcedure: urine specimenProcedure: Nasopharyngeal swabProcedure: sputum
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 5172
- Registration Number
- NCT00929721
- Locations
- 🇵🇱
Pfizer Investigational Site, Chrzanow, Poland
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
Phase 1
Completed
- Conditions
- Colitis, Ulcerative
- Interventions
- Biological: Single dose-group ABiological: Multiple dose- Group BBiological: Multiple dose-Group B
- First Posted Date
- 2009-06-26
- Last Posted Date
- 2009-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 80
- Registration Number
- NCT00928681
- Locations
- 🇪🇸
Pfizer Investigational Site, Madrid, Spain
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 566
- Registration Number
- NCT00928070
- Locations
- 🇺🇸
Pfizer Investigational Site, Spokane, Washington, United States
A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-12-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT00928278
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 37
- Registration Number
- NCT00927823
- Locations
- 🇺🇸
Pfizer Investigational Site, Buffalo, New York, United States
Study Evaluating Renal Cell Carcinoma Risk Factors
Completed
- Conditions
- Carcinoma, Renal Cell
- Interventions
- Other: Epidemiological study according to clinical practice
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2011-11-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 145
- Registration Number
- NCT00927043
- Locations
- 🇪🇸
Pfizer Investigational Site, Pamplona, Navarra, Spain
© Copyright 2025. All Rights Reserved by MedPath